Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-17

Clinical Trial Update: Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of mecamylamine in smoking and non-smoking patients with alcoholism completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mecamylamine (mecamylamine)

Snippet

Sponsor: Yale University | Conditions: Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2017-05-17